Parallax Volatility Advisers, L.P. Acadia Pharmaceuticals Inc Transaction History

Parallax Volatility Advisers, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $17,787 - $27,195	856 New	856 $26,000
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $41,697 - $53,450	2,555 New	2,555 $48,000
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $2.1 Million - $2.91 Million	-51,217 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $1.87 Million - $2.92 Million	51,217 New	51,217 $2.11 Million
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $258 - $438	-16 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $11,126 - $17,808	-777 Reduced 97.98%	16 $0
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $638 - $1,068	-49 Reduced 5.82%	793 $16,000
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $3,541 - $5,249	235 Added 38.71%	842 $13,000
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $291,885 - $425,647	-10,875 Reduced 94.71%	607 $18,000
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $338,604 - $440,564	11,482	11,482 $433,000

284

158M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.02B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.